Company: BWNB
Filing Date: 2025-06-10
Form Type: 424B5
Source: 0001104659-25-058204
Chunk: 0

Company: Babcock & Wilcox Enterprises, Inc.
Filing Date: 2025-06-10
Form: 424B5
Chunk 0
---
Filed Pursuant to Rule 424(b)(5)

Registration No. 333-283368

PROSPECTUS SUPPLEMENT
(To prospectus dated April 8, 2025)

<div align='center'>Up to $50,000,000

Babcock & Wilcox Enterprises, Inc.

Common Stock</div>

Babcock &
Wilcox Enterprises, Inc., Lake Street Capital Markets, LLC (“Lake Street”) and Craig-Hallum Capital Group LLC
(“Craig-Hallum”, and together with Lake Street the “Agents”) are parties to a sales
agreement (the “Sales Agreement”), under which we may offer and sell, from time to time, up to $50,000,000 of our common
stock, par value $0.01 per share (the “Common Stock”). In accordance with the terms of the Sales Agreement, we have sold
under a prospectus supplement, dated April 10, 2024, shares of our Common Stock having an aggregate offering price of approximately
$14.11 million. Pursuant to this prospectus supplement, we may offer and sell shares of our Common Stock having an aggregate
offering price of up to approximately $35.89 million.

Our Common Stock is listed
on the New York Stock Exchange (“NYSE”) under the symbols “BW”. The last reported sale price of our Common Stock
on June 9, 2025 was $1.17 per share.

The securities to which this
prospectus supplement and the accompanying prospectus relate will be offered and sold through the Agents over a period of time and from
time to time by any method that is deemed to be an “at the market offering” as defined in Rule 415 promulgated under
the Securities Act of 1933, as amended (the “Securities Act”). The Agents are not required to sell any specific number of
shares of our Common Stock, but will act as our sales agents using commercially reasonable efforts consistent with their normal trading
and sales practices, on mutually agreed terms between the Agents and us. Under the Sales Agreement, the Agents will be entitled to compensation
equal to 3.0% of the gross sales price of all shares of our Common Stock sold through them as our agents. In connection with the sale
of Common Stock on our behalf, the Agents will be deemed to be “underwriters” within the meaning of the Securities Act and
the compensation of the Agents will be deemed to be underwriting commissions or